Erythema News and Research

RSS
Durata completes target enrollment in dalbavancin Phase 3 trials for abSSSI

Durata completes target enrollment in dalbavancin Phase 3 trials for abSSSI

Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid lupus erythematosus

Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid lupus erythematosus

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

Soft implants preferable for nose augmentation

Soft implants preferable for nose augmentation

Treatments for peripheral neuropathic pain compared

Treatments for peripheral neuropathic pain compared

Young women with indoor tanning habits frequently experience sunburn

Young women with indoor tanning habits frequently experience sunburn

Five abstracts evaluating Abbott's LCIG presented at Parkinson's disease congress

Five abstracts evaluating Abbott's LCIG presented at Parkinson's disease congress

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

FDA approves Protalix, Pfizer’s ELELYSO for treatment of type 1 Gaucher disease

FDA approves Protalix, Pfizer’s ELELYSO for treatment of type 1 Gaucher disease

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

Merck announces data from ZOSTAVAX Phase III study on shingles

Merck announces data from ZOSTAVAX Phase III study on shingles

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis

Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis

New gel could nip Lyme borreliosis infection in the bud

New gel could nip Lyme borreliosis infection in the bud

Positive results from NeuroDerm's ND0611 Phase I/II study for advanced Parkinson's disease

Positive results from NeuroDerm's ND0611 Phase I/II study for advanced Parkinson's disease

HyQ phase III study data in patients with primary immunodeficiencies presented at ACAAI meeting

HyQ phase III study data in patients with primary immunodeficiencies presented at ACAAI meeting

ORENCIA SC formulation receives FDA approval for treatment of adults with RA

ORENCIA SC formulation receives FDA approval for treatment of adults with RA

Grapes help protect skin cells from sun's UV radiation

Grapes help protect skin cells from sun's UV radiation

Yaupon seeks FDA marketing approval of mechlorethamine gel for mycosis fungoides

Yaupon seeks FDA marketing approval of mechlorethamine gel for mycosis fungoides